Alzheimer's & Cognition
From the Journals
Hearing loss strongly tied to increased dementia risk
Even mild hearing loss was associated with increased dementia risk.
Commentary
Age competency exams for physicians – yes or no?
Almost one-third of licensed doctors in the United States were 60 years of age or older, according to a survey conducted in 2020.
FDA/CDC
What to know about newly approved Alzheimer’s drug
The drug has shown moderate positive effects in clinical trials in slowing early...
FDA/CDC
FDA approves second antiamyloid for Alzheimer’s disease
Like its controversial cousin aducanumab, lecanemab was approved under the FDA’s accelerated approval pathway.
FDA/CDC
FDA considers regulating CBD products
The products can have drug-like effects on the body and contain CBD (cannabidiol) and THC (tetrahydrocannabinol).
From the Journals
Strong link between muscle strength, mobility, and brain health
“The implication is that muscular strength and mobility influence brain health.”
News from the FDA/CDC
Alzheimer’s Association to CMS: Ditch restraints on amyloid drugs
The CMS coverage restrictions for anti-amyloid drugs were finalized in April on the...
Conference Coverage
Antipsychotic shows benefit for Alzheimer’s agitation
Currently, there’s no Food and Drug Administration–approved treatment for agitation in AD.
Commentary
Mindfulness, exercise strike out in memory trial
Meditation and exercise do not appear to be the fountain of youth.
From the Journals
Noninvasive laser therapy tied to improved short-term memory
Patients with attention-related conditions ‘could benefit from this type of treatment,’ expert says.
Conference Coverage
Seizures in dementia hasten decline and death
Dementia patients who also had active seizures had shorter life expectancy and earlier decline than dementia patients who didn’t have active...